<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.37912.024</object-id><label>Table 2.</label><caption><title>DNA binding, NAD<sup>+&#160;</sup>binding and catalytic activity of ERM-BP-WT and ERM-BP mutants.</title><p>Wild type (WT) and mutant ERM-BP proteins were analyzed by three approaches. DNA binding was determined by EMSA analysis with increasing concentration of NAD<sup>+</sup>. Protein thermal shift assay was performed to determine NAD<sup>+</sup> binding and melting temperature (Tm) in the presence of varying concentration of NAD<sup>+</sup> is shown. Nicotinamidase activity was determined by measuring conversion of nicotinamide to nicotinic acid by HPLC.</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>Proteins</th><th colspan="3">DNA Binding (EMSA) <break/>NAD<sup>+</sup> (mM)#</th><th colspan="4">NAD+ Binding (Tm) <break/>NAD<sup>+</sup> (mM)&#167;</th><th>Nicotinamidase activity (% <break/>conversion)&#182;</th></tr><tr valign="top"><th/><th>0</th><th>1</th><th>4</th><th>0</th><th>1</th><th>4</th><th>P-values <break/>(0-4)</th><th/></tr></thead><tbody><tr valign="top"><td>1. GST&#8224;</td><td>-</td><td>-</td><td>-</td><td>52&#160;&#177;&#160;7.0</td><td>53&#160;&#177;&#160;7.0</td><td>51&#160;&#177;&#160;7.0</td><td>0.6549</td><td>no conversion</td></tr><tr valign="top"><td>2. ERM-BP-WT&#8225;</td><td>++</td><td>+++</td><td>++++</td><td>57&#160;&#177;&#160;0.3</td><td>60&#160;&#177;&#160;0.7</td><td>62&#160;&#177;&#160;1.3</td><td>1.1E-08</td><td>52 &#177;&#160;0.6</td></tr><tr valign="top"><td>3. D12A&#8225;</td><td>+/-</td><td>++</td><td>+++</td><td>57&#160;&#177;&#160;1.0</td><td>59&#160;&#177;&#160;1.0</td><td>62&#160;&#177;&#160;1.0</td><td>1.5E-08</td><td>no&#160;conversion</td></tr><tr valign="top"><td>4. ERM-BP-DBM&#8225;</td><td>-</td><td>-</td><td>++</td><td>57&#160;&#177;&#160;0.3</td><td>58&#160;&#177;&#160;0.8</td><td>61&#160;&#177;&#160;1.0</td><td>9.9E-09</td><td>50&#160;&#177;&#160;2.1</td></tr><tr valign="top"><td>5. K150A&#8225;</td><td>+/-</td><td>++</td><td>+++</td><td>58&#160;&#177;&#160;1.7</td><td>59&#160;&#177;&#160;1.0</td><td>62&#160;&#177;&#160;11</td><td>3.7E-05</td><td>no&#160;conversion</td></tr><tr valign="top"><td>6. C198A&#8224;</td><td>-</td><td>-</td><td>-/+</td><td>57&#160;&#177;&#160;0.3</td><td>57&#160;&#177;&#160;0.4</td><td>57&#160;&#177;&#160;0.5</td><td>0.3796</td><td>no&#160;conversion</td></tr></tbody></table><table-wrap-foot><fn><p># EMSA (Electrophoretic mobility shift assay) with varying amounts of NAD<sup>+</sup> (0, 1, 4 mM): &#8216;++++' indicates strong binding, &#8216;+++' and &#8216;++' indicate moderate, &#8216;+/-' indicates weak binding and '-'&#8220;indicates no binding. &#167; NAD<sup>+</sup> binding was monitored by protein thermal shift assay with varying amounts of NAD<sup>+</sup> (0, 1, 4 mM). The Tm (melting temperature) is shown as mean&#160;&#177;s.d. (n&#160;=&#160;3) Student&#8217;s t-test; p-values are shown between NAD<sup>+</sup> 0 mM and 4 mM concentrations. &#182; The turnover of nicotinamide to nicotinic acid by ERM-BP-WT and mutant recombinant proteins are shown as percentage conversion mean&#160;&#177;s.d. (n&#160;=&#160;3). &#8225; Indicates having significant effects in DNA /NAD<sup>+</sup> binding and catalytic activity, &#8224; Indicates not having significant effects in DNA/NAD<sup>+</sup> binding and catalytic activity.</p></fn></table-wrap-foot></table-wrap>